Market Cap : 9.78 B | Enterprise Value : 15.57 B | PE Ratio : At Loss | PB Ratio : 1.28 |
---|
NYSE:ELAN has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NYSE:ELAN has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Elanco Animal Health has the Profitability Rank of 5.
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way. It is based on these factors:
1. Operating Margin %Elanco Animal Health's Operating Margin % for the quarter that ended in Mar. 2022 was 14.53%. As of today, Elanco Animal Health's Piotroski F-Score is 6.
For the Drug Manufacturers - Specialty & Generic subindustry, Elanco Animal Health's Profitability Rank, along with its competitors' market caps and Profitability Rank data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Drug Manufacturers industry and Healthcare sector, Elanco Animal Health's Profitability Rank distribution charts can be found below:
* The bar in red indicates where Elanco Animal Health's Profitability Rank falls into.
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.
The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.
Elanco Animal Health has the Profitability Rank of 5.
Profitability Rank is not directly related to the Financial Strength. But if a company is consistently profitable, its financial strength will be stronger.
Profitability Rank is based on these factors:
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
Elanco Animal Health's Operating Margin % for the quarter that ended in Mar. 2022 is calculated as:
Operating Margin % | = | Operating Income (Q: Mar. 2022 ) | / | Revenue (Q: Mar. 2022 ) |
= | 178 | / | 1225 | |
= | 14.53 % |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The zones of discrimination were as such:
Good or high score = 8 or 9
Bad or low score = 0 or 1
Elanco Animal Health has an F-score of 6 indicating the company's financial situation is typical for a stable company.
3. Trend of the Operating Margin % (5-year average). The company with an uptrend profit margin has a higher rank.
4. Consistency of the profitability
5. Predictability Rank
Thank you for viewing the detailed overview of Elanco Animal Health's Profitability Rank provided by GuruFocus.com. Please click on the following links to see related term pages.
Meer James M | officer: Chief Accounting Officer | C/O ELANCO ANIMAL HEALTH, INC. 2500 INNOVATION WAY GREENFIELD IN 46140 |
Ehle Dirk | officer: Ex VP & Pres Elanco Europe | C/O ELANCO ANIMAL HEALTH INCORPORATED 2500 INNOVATION WAY GREENFIELD IN 46140 |
Lee Joyce J. | officer: Ex VP Prs US Pet Hlth Com Op | C/O ZOETIS INC. 100 CAMPUS DRIVE FLORHAM PARK NJ 07940 |
Urbanek David Alan | officer: See Remarks | 2500 INNOVATION WAY GREENFIELD IN 46140 |
Schacht Aaron L | officer: See Remarks | 3750 BIRKDALE DR CARMEL IN 46033 |
Hoover R David | director, See Remarks | C/O EDGEWELL PERSONAL CARE COMPANY 1350 TIMBERLAKE MANOR PARKWAY CHESTERFIELD MO 63017 |
Bilbrey John P | director | PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"> Ownership Information: BILBREY JOHN P a.header:link {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:visited {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:hover {color: #191970;} |
Garcia Art A | director | 11690 N.W. 105TH STREET MIAMI FL 33178 |
Young Todd S. | officer: See Remarks | C/O ACADIA PHARMACEUTICALS INC. 3611 VALLEY CENTRE DRIVE, SUITE 300 SAN DIEGO CA 92130 |
Bayer Aktiengesellschaft | 10 percent owner | BAYERWERK, GEBAEUDE W11 KAISER-WILHELM-ALLEE LEVERKUSEN 2M D-51368 |
Bayer World Investments B.v. | 10 percent owner | ENERGIEWEG 1 MIJDRECHT P7 3641 |
Mason Racquel Harris | officer: See Remarks | C/O ELANCO ANIMAL HEALTH INCORPORATED 2500 INNOVATION WAY GREENFIELD IN 46140 |
Correia De Simas Jose Manuel | officer: See Remarks | C/O ELANCO ANIMAL HEALTH INCORPORATED 2500 INNOVATION WAY GREENFIELD IN 46140 |
Harrington Michael J | director | LILLY CORPORATE CENTER INDIANAPOLIS IN 46285 |
Anand Kapila K | director | C/O EXTENDED STAY AMERICA, INC. 11525 N. COMMUNITY HOUSE ROAD, SUITE 100 CHARLOTTE NC 28277 |
Other Sources
By Zacks 2021-11-05
By Zacks 2021-06-09
By Fool 2021-09-07
By Zacks 2021-08-05
By Zacks 2021-05-07
By Zacks 2021-05-06
By Zacks 2021-06-11
By Zacks 2022-02-24
By Zacks 2021-05-21
By Seekingalpha 2022-02-24